These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 29490096)

  • 21. The effect of casein glycomacropeptide versus free synthetic amino acids for early treatment of phenylketonuria in a mice model.
    Ahring KK; Dagnæs-Hansen F; Brüel A; Christensen M; Jensen E; Jensen TG; Johannsen M; Johansen KS; Lund AM; Madsen JG; Brøndum-Nielsen K; Pedersen M; Sørensen LK; Kjolby M; Møller LB
    PLoS One; 2022; 17(1):e0261150. PubMed ID: 35015767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study.
    Fu BC; Hullar MAJ; Randolph TW; Franke AA; Monroe KR; Cheng I; Wilkens LR; Shepherd JA; Madeleine MM; Le Marchand L; Lim U; Lampe JW
    Am J Clin Nutr; 2020 Jun; 111(6):1226-1234. PubMed ID: 32055828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

  • 24. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density.
    Lage S; Bueno M; Andrade F; Prieto JA; Delgado C; Legarda M; Sanjurjo P; Aldámiz-Echevarría LJ
    J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S363-71. PubMed ID: 20830525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lower n-3 long-chain polyunsaturated fatty acid values in patients with phenylketonuria: a systematic review and meta-analysis.
    Lohner S; Fekete K; Decsi T
    Nutr Res; 2013 Jul; 33(7):513-20. PubMed ID: 23827125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbohydrate status in patients with phenylketonuria.
    Couce ML; Sánchez-Pintos P; Vitoria I; De Castro MJ; Aldámiz-Echevarría L; Correcher P; Fernández-Marmiesse A; Roca I; Hermida A; Martínez-Olmos M; Leis R
    Orphanet J Rare Dis; 2018 Jun; 13(1):103. PubMed ID: 29945661
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
    Pena MJ; Pinto A; Daly A; MacDonald A; Azevedo L; Rocha JC; Borges N
    Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The phenylketonuria patient: A recent dietetic therapeutic approach.
    Manta-Vogli PD; Dotsikas Y; Loukas YL; Schulpis KH
    Nutr Neurosci; 2020 Aug; 23(8):628-639. PubMed ID: 30359206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria.
    Yi SH; Kable JA; Evatt ML; Singh RH
    J Inherit Metab Dis; 2011 Apr; 34(2):455-63. PubMed ID: 21305356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.
    Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Strauss BJ; Wilcox G; Rocha JC; Ashmore C; MacDonald A
    Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigation of paediatric PKU breath malodour, comparing glycomacropeptide with phenylalanine free L-amino acid supplements.
    Tiele A; Daly A; Hattersley J; Pinto A; Evans S; Ashmore C; MacDonald A; Covington JA
    J Breath Res; 2019 Oct; 14(1):016001. PubMed ID: 31476741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in the nutritional and pharmacological management of phenylketonuria.
    Ney DM; Blank RD; Hansen KE
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilisation of amino acid mixtures in adolescents with phenylketonuria.
    Mönch E; Herrmann ME; Brösicke H; Schöffer A; Keller M
    Eur J Pediatr; 1996 Jul; 155 Suppl 1():S115-20. PubMed ID: 8828625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nutritional management of PKU with glycomacropeptide from cheese whey.
    Ney DM; Gleason ST; van Calcar SC; MacLeod EL; Nelson KL; Etzel MR; Rice GM; Wolff JA
    J Inherit Metab Dis; 2009 Feb; 32(1):32-9. PubMed ID: 18956251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large neutral amino acid supplementation increases melatonin synthesis in phenylketonuria: a new biomarker.
    Yano S; Moseley K; Azen C
    J Pediatr; 2013 May; 162(5):999-1003. PubMed ID: 23164313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
    Daly A; Evans S; Chahal S; Santra S; MacDonald A
    J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. L-carnitine blood levels and oxidative stress in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; de Mari JF; Barden AT; Vanzin CS; Biancini GB; Schwartz IV; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2009 Mar; 29(2):211-8. PubMed ID: 18814025
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosine metabolism in health and disease: slow-release amino acids therapy improves tyrosine homeostasis in phenylketonuria.
    Porta F; Giorda S; Ponzone A; Spada M
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1519-1523. PubMed ID: 33581706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.